Biogen Inc. (0R1B.L) LSE

176.76

+1.4038(+0.80%)

Updated at December 24 05:24PM

Currency In USD

Valuation

Market Cap22.28B
Enterprise Value26.54B
P/E Ratio16.07
PEG Ratio3.31
Price/Sales Ratio2.57
Price/Book Ratio1.42
Enterprise/Revenue2.84
Enterprise/EBITDA8.19

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.16
Operating Margin0.24

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue9.68B
Revenue/Share68.66
Gross Profit7.37B
EBITDA3B
Net Income1.63B
Diluted EPS11.19

Balance Sheet

Total Cash3.96B
Total Cash/Share27.02
Total Debt6.59B
Total Debt/Equity0.36
Current Ratio2.72
Book Value Per Share124.2

Price History

52-Week Change18.08
52-Week High176.94
52-Week Low173.58
Moving Average 50 Days164.66
Moving Average 200 Days140.81

Statistics

Average Volume3,293.37
Shares Outstanding146.7M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A